Skip to main content

SpringWorks Therapeutics, Inc.

SWTXDelisted Jul 1, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001773427

SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2024 vs. Q1 2024

How the institutions holding SpringWorks Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of SWTX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2172209−6
Shares78.3M60.0K77.2M−1.05M (−1.3%)
Value$3.85B$2.95M$2.91B−$941.6M (−24.5%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held SpringWorks Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to SWTX in Q2 2024
InstitutionSharesValue% of portfolio
Duquesne Family Office LLCSuperinvestorDuquesne Family Office1,021,367$38.5M1.36%
Eagle Asset Management Inc327,845$12.6M0.07%
Rock Springs Capital Management LP199,855$7.53M0.23%
Segall Bryant & Hamill, LLC140,441$5.29M0.09%
Man Group plc56,091$2.11M0.01%
Seven Eight Capital, LP49,224$1.85M0.19%
Two Sigma Advisers, LP42,000$1.58M0.00%
Mirae Asset Global ETFs Holdings Ltd.40,036$1.51M0.00%
Corebridge Financial, Inc.36,984$1.39M0.01%
BIT Capital GmbH21,020$791.8K0.07%
Guggenheim Capital LLC19,185$722.7K0.01%
XTX Topco Ltd16,491$621.2K0.05%
Magnetar Financial LLC13,338$502.4K0.01%
Brevan Howard Capital Management LP12,437$468.5K0.03%
Pathstone Holdings, LLC11,291$425.3K0.00%
Raymond James & Associates10,421$392.6K0.00%
Bayesian Capital Management, LP8,814$332.0K0.04%
Verition Fund Management LLC8,674$326.8K0.00%
Nebula Research & Development LLC6,892$259.6K0.04%
Allspring Global Investments Holdings, LLC3,278$123.5K0.00%
Lazard Asset Management LLC2,409$90.0K0.00%
Huntington National Bank512$19.3K0.00%
Clearstead Advisors, LLC346$13.0K0.00%
Ashton Thomas Private Wealth, LLC345$13.0K0.00%
SYSTM Wealth Solutions LLC255$9.61K0.00%
Hillsdale Investment Management Inc.130$4.90K0.00%
Smartleaf Asset Management LLC120$4.50K0.00%
SRS Capital Advisors, Inc.81$3.05K0.00%
Itau Unibanco Holding S.A.32$1.21K0.00%
Innealta Capital, LLC32$1.21K0.00%
Institutional & Family Asset Management, LLC18$6780.00%

Sold out (37)

Institutions that held SpringWorks Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of SWTX in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Point72 Asset Management, L.P.1,489,814$73.3M
Deerfield Management Company, L.P. (Series C)1,283,176$63.2M
Rubric Capital Management LP426,768$21.0M
Altitude Crest Partners Inc.128,842$6.34M
Polar Asset Management Partners Inc.128,000$6.30M
Jefferies Financial Group Inc.68,667$3.38M
Alps Advisors Inc52,048$2.56M
Lighthouse Investment Partners, LLC40,733$2.00M
American International Group, Inc.33,751$1.66M
Moody Aldrich Partners LLC18,080$889.9K
Campbell & CO Investment Adviser LLC16,644$819.2K
Bank of Montreal14,685$757.2K
Squarepoint Ops LLC15,034$740.0K
Silphium Asset Management Ltd10,000$492.2K
Dynamic Technology Lab Private Ltd8,260$407.0K
New York Life Investment Management LLC7,248$356.7K
Creative Planning5,246$258.2K
Farallon Capital Management, L.L.C.5,000$246.1K
Financial Security Advisor, Inc.5,000$246.1K
Prudential Financial Inc4,894$240.9K
Bayshore Asset Management, LLC4,852$238.8K
SG Americas Securities, LLC4,673$230.0K
Xponance, Inc.4,164$205.0K
Mackenzie Financial Corp4,137$203.6K
Jump Financial, LLC4,075$200.6K
Caption Management, LLC4,000$196.9K
Metropolitan Life Insurance Co3,670$180.6K
Headlands Technologies LLC2,123$104.5K
Walleye Trading LLC1,493$73.5K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC288$14.2K
nVerses Capital, LLC100$4.92K
Hollencrest Capital Management98$4.82K
Westend Capital Management, LLC28$1.38K
Quadrant Capital Group LLC23$1.13K
Geneos Wealth Management Inc.20$984
Parallax Volatility Advisers, L.P.16$788
Riggs Asset Managment Co. Inc.7$345

Not filed for Q2 2024 yet (2)

Institutions that held SpringWorks Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SWTX in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG59,198$2.91M
Cutler Group LP810$39.0K